MENU
The Epoch Times
    SEARCH
  • HOME
  • TODAY'S HEADLINES
  • EDITOR'S PICKS
  • TOP NEWS
  • MOST POPULAR
  • HOW THE SPECTER OF COMMUNISM IS RULING OUR WORLD
  • EpochTV
  • Health
    • Health News
    • Conditions
    • Experts
    • Traditional Chinese Medicine
    • Life & Wellness
  • Magazines
    • Epoch Insight
    • American Essence
    • Epoch Health
    • Mind & Body
    • Arts & Culture
    • Life & Tradition
    • China Insider
    • Special Series
  • US
    • US Features
    • US Politics
    • Crime and Incidents News
    • New York
    • San Francisco
    • Los Angeles
  • China News
    • US-China Relations
    • Chinese Regime
    • China Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Nine Commentaries
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • International
    • Middle East
    • Australia News
    • UK News
  • Opinion
    • Thinking About China
    • Viewpoints
    • DECLASSIFIED
    • AMERICAN THOUGHT LEADERS
  • Business
    • Companies
    • Economy
    • Markets
    • Real Estate
  • Science
    • Science News
    • Space
    • Environment
  • Bright
    • Lifestyle
    • Inspired
    • Arts & Culture
    • Family & Education
    • Personal Finance
    • American Essence
  • Arts & Culture
    • Shen Yun Special Coverage
    • Performing Arts
    • Fine Arts
    • Books
  • Entertainment
    • Film
    • Film & TV
    • Entertainment News
  • Life & Tradition
    • People
    • Inspired
    • Careers
    • Family & Education
    • Travel
  • Hong Kong
  • Games
  • SPORTS
  • FOOD
  • VIDEO
  • Edition
    • UNITED STATES
    • CANADA
    • AUSTRALIA
    • UK, EUROPE
  • NEWSSTANDS
  • Epoch Shop
  • Gift
  • DONATION
    • VEHICLE DONATION

antibody

  • COVID ‘FLiRT’ Variants Are Spreading–Here’s What to Know
    COVID ‘FLiRT’ Variants Are Spreading–Here’s What to Know
    915d BY Yuhong Dong
  • GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    1466d BY Reuters
  • IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study
    IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study
    1689d BY Mimi Nguyen Ly
  • Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
    1793d BY Reuters
  • Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement
    Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement
    1904d BY Meiling Lee
  • UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People
    UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People
    1908d BY PA Media
  • NTD Evening News Full Broadcast (Aug. 20)
    NTD Evening News Full Broadcast (Aug. 20)
    1910d BY NTD Television
  • BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
    BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
    1944d BY Alex Wu
  • Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
    Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
    1990d BY Meiling Lee
  • Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study
    Elderly Show Similar Antibody Response to 1st Dose of AstraZeneca, Pfizer COVID-19 Shots: UK Study
    2038d BY Reuters
  • Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says
    Get Used to Annual Revaccination Against COVID-19, Boris Johnson Says
    2101d BY Alexander Zhang
  • UK Identifies 2 More COVID-19 Variants With Vaccine-Resistant Mutation
    UK Identifies 2 More COVID-19 Variants With Vaccine-Resistant Mutation
    2102d BY Alexander Zhang
  • Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections
    Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections
    2117d BY Zachary Stieber
  • FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance
    2194d BY Isabel van Brugen
  • More Test Positive in Expanded New York Antibody Testing
    More Test Positive in Expanded New York Antibody Testing
    2390d BY Zachary Stieber
  • Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    2397d BY Zachary Stieber
The Epoch Times
LANGUAGES
  • Bulgarian
  • English
  • Chinese
  • Spanish
  • Hebrew
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Greek
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
DOWNLOAD OUR APP
iOS Android
  • Help Center
  • Subscribe
  • Media Statements
  • About Us
  • FAQ
  • Contact Us
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Data Disclaimer
  • Our Story
COPYRIGHT © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top